Evidence map›Paper›PMID 35634313›Full record

ArticleFrontiers in immunology2022

Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients.

Fadime Ceyda Eldeniz, Yahya Gul, Alaaddin Yorulmaz, Sukru Nail Guner, Sevgi Keles, Ismail Reisli

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Case Report: Novel variants in theFrontiers in immunology · 2025
    Article
  10. Nutritional status in pediatric patients with predominant antibody deficiencyBiomedica : revista del Instituto Nacional de Salud · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fadime Ceyda EldenizDepartment of Pediatrics, Necmettin Erbakan University, Konya, Turkey.
Yahya GulDepartment of Pediatric Allergy and Immunology, Necmettin Erbakan University, Konya, Turkey.
Alaaddin YorulmazDepartment of Pediatrics, Selcuk University, Konya, Turkey.
Sukru Nail GunerDepartment of Pediatric Allergy and Immunology, Necmettin Erbakan University, Konya, Turkey.
Sevgi KelesDepartment of Pediatric Allergy and Immunology, Necmettin Erbakan University, Konya, Turkey.
Ismail ReisliDepartment of Pediatric Allergy and Immunology, Necmettin Erbakan University, Konya, Turkey.
Necmettin Erbakan University · TRSelçuk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Ten warning signs of primary immunodeficiency (PID) were suggested by the Jeffrey Modell Foundation (JMF), to increase physician awareness of PID. These warning signs have not yet been evaluated for patients with secondary immunodeficiency (SID). This study investigated whether the 10 warning signs used for the diagnosis of PID were also sufficient for the diagnosis of SID, and explored the possibility of additional signs. Methods: This prospective study was conducted between June and December 2020. The mothers of 162 patients with PID and SID, and mothers of 200 healthy children, were asked to complete a questionnaire about family and personal history in addition to the warning signs of PID developed by the JMF. A JMF score was created by giving one point for each "Yes" answer for the 10 warning signs of PID. Medical records of the patients were evaluated for possible additional warning signs for PID and SID. Results: The JMF scores of the PID (3.36 ± 1.65) and SID (3.72 ± 1.12) groups were significantly higher than the scores of the control group (0.34 ± 0.61) (p < 0.05). A sign for immunological evaluation in two patients without warning signs in the PID group was found to be chronic diarrhea. In addition to the 10 JMF warning signs, we found that consanguinity and a family history of tuberculosis were statistically significant in our PID group, compared with the SID and control groups. Conclusions: The JMF warning signs are important for early diagnosis of PID. Our study showed that these signs may also be used for the early diagnosis of SID in patients and, according to our results, in addition to the 10 JMF signs for PID, parental consanguinity, chronic diarrhea, and a family history of tuberculosis may also be considered warning signs for the early diagnosis of PID.

Indexed as

Immunologic Deficiency SyndromesChildDiarrheaHumansMedical History TakingProspective Studies10 warning signschildhoodcombined immunodeficiencyprimary immunodeficiencysecondary immunodeficiency

Identifiers

PMID35634313
PMCPMC9136241
OpenAlexW4280584150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.